Effects of the benzodiazepine inverse agonist RO19-4603 alone and in combination with the benzodiazepine receptor antagonists flumazenil, ZK 93426 and CGS 8216, on ethanol intake in alcohol-preferring (P) rats

Brain Research

Volumn 734, Issue 1-2, 1996, Pages 19-34

  June, Harry L ^a   Greene, Terri L ^a   Murphy, James M ^a   Hite, Margaret L ^a   Williams, John A ^a   Cason, Charity R ^a   Mellor Burke, Jackie ^a   Cox, Rhonda ^a   Duemler, Scott E ^a   Torres, Lucas ^a   Lumeng, Lawrence ^a,b   Li, Ting Kai ^a  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AlcohoI preferring (P) rat; Benzdiazepine inverse agonist; Benzodiazepine antagonist; CGS 8216; Flumazenil; GABA(A) BDZ; RO19 4603; ZK 93426

Indexed keywords

2 PHENYL 5H PYRAZOLO[4,3 C]QUINOLIN 3 ONE; 5 ISOPROPOXY 4 METHYL BETA CARBOLINE 3 CARBOXYLIC ACID ETHYL ESTER; 5,6 DIHYDRO 5 METHYL 6 OXO 4H IMIDAZO[1,5 A]THIENO[2,3 F][1,4]DIAZEPINE 3 CARBOXYLIC ACID TERT BUTYL ESTER; ALCOHOL; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; FLUMAZENIL; SACCHARIN;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030599140     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00276-4     Document Type: Article

References (58)

1. [1] Bagust, J., Gardner, C.R., Walker, R.J. and Ward, R.A., Studies in efficacy of low affinity benzodiazepine receptor ligand on rat cerebellar slice activity, [abstract] Br. J. Pharmacol., 99 (1990) 252.
2. [2] Balakleevsky, A., Colombo, G., Fadda, F. and Gessa, G.L., Ro19-4603, a benzodiazepine receptor inverse agonist attenuates voluntary ethanol consumption in rats selectively bred for high ethanol preference, Alcohol Alcohol., 25 (1990) 449.
3. [3] Barrett, J.E., Brady, L.S. and Witkin, J.M., Behavioral studies with anxiolytic drugs I. Interaction of the benzodiazepine antagonist RO15-1788 with chlordiazepoxide, pentobarbital and ethanol, J. Pharmacol. Exp. Ther., 233 (1985) 554-559.
4. [4] Belzung, C., Vogel, E. and Misslin, R., Benzodiazepine antagonist RO15-1788 partly reverses some anxiolytic effects of ethanol in the mouse, Psychopharmacology (Berlin), 95 (1981) 516-519.
5. [5] Bernard, P., Bergen, K., Sobiski, R. and Robson, R.D., CGS 8216 (2-Phenylpyrazolo[4,3-c] quinoline-3 (5H)-one), an orally effective benzodiazepine antagonist, Pharmacology, 23 (1981) 150.
6. [6] Bonetti, E.P., Pieri, L., Cumin, R., Schaffner, R. Fieri, M., Gamzu, E.R., Muller, R.M. and Haefely, W., Benzodiazepine antagonist RO15-1788: neurological and behavioral effects, Psychopharmacology (Berlin), 78 (1982) 8-18.
7. A receptor-operated chloride channels: II. Chronic effects of ethanol, J. Pharmacol. Exp. Ther., 253 (1990) 713-719.
8. [8] Buck, K.J., Heather, H. and Harris, R.A., Reversal of alcohol dependence and tolerance by a single administration of flumazenil, J. Pharmacol. Exp. Ther., 257 (1991) 984-989.
9. [9] Cloninger, C.R., Neurogenetic adaptive mechanisms in alcoholism, Science, 36 (1987) 410-416.
10. [10] Cooper, S.J., Kirkham, T.C. and Estall, L.B., Pyrazoloquinolines: second generation benzodiazepine receptor ligands have heterogeneous effects, Trends Pharmacol. Sci., 8 (1987) 180-184.
11. [11] Czernik, A.J., Petrack, B., Kalinsky, H.J., Psychoyos, S., Cash, W.D., Tsai, C., Rinehart, R.K., Granat, F.R., Lovell, R.A., Brundish, D.E. and Wade, R., CGS 8216: receptor binding characteristics of a potent benzodiazepine antagonist, Life Sci., 30 (1982) 363-372.
12. [12] File, S.E. and Lister, R.G., Quinolines and anxiety: anxiogenic effects of CGS 8216 and partial anxiolytic profile of PK 9084, Pharmacol. Biochem. Behav., 18 (1983) 185-188.
13. [13] File, S.E. and Pellow, S., Intrinsic actions of the benzodiazepine receptor antagonist RO 15-1788, Psychopharmacology (Berlin), 88 (1986) 1-11.
14. [14] File, S.E., Baldwin, H.A. and Hitchcott, P.K., Flumazenil but not nitrendipine reverses the increased anxiety during ethanol withdrawal in the rat, Psychopharmacology (Berlin), 98 (1989) 262-264.
15. [15] Haefely, W., Facklam, M., Schoch, P., Martin, J.R., Bonetti, E.P., Moreau, J.-L., Jenck, F. and Richards, J.G., Partial agonists of benzodiazepine receptors for the treatment of epilepsy, sleep, and anxiety disorders. In G. Biggio, A. Concas and E. Costa (Eds.), GABAergic Synaptic Transmission, Raven Press, New York, 1992, pp. 379-394.
16. [16] Harris, C.M. and Lal, H., Central nervous system effects of RO15-4513, Drug Dev. Res. , 13 (1988) 187-203.
17. [17] Hewitt, R.L., June, H.L., Murphy, J.M., Greene, T.L., Lin, M., Mellor-Burke, J.J., Lumeng, L. and Li, T.-K., Does tolerance develop to the ethanol suppressant effects of the benzodiazepine receptor inverse agonist, RO19-4603? Alcohol. Clin. Exp. Res., 18 (1994) 487.
18. [18] Hunkeler, W., Preclinical research findings with flumazenil (RO15-1788, anexate): chemistry, Eur. J. Anesth., 2 (1988) 37-38.
19. [19] Hunkeler, W., Mohler, L., Pieri, L., Polc, P., Bonnetti, E.P., Cumin, R., Schaffer, R. and Haefley, W., Selective antagonist of bezodiazepines, Nature, 290 (1984) 514.
20. [20] Hwang, B.H., Lumeng, L., Wu, J.Y. and Li, T.-K., Increased number of GABAergic terminals in the nucleus accumbens is associated with alcohol preference in rats, Alcohol. Clin. Exp. Res., 14 (1990) 503-507.
21. [21] Jackson, H.C. and Nutt, D.J., Inverse agonist and alcohol. In Benzodiazepine Receptor Inverse Agonists, Wiley-Liss, 1995, pp. 113-138.
22. [22] Jensen, L.H., Peterson, E.N., Braestrup, C., Honore, T., Kehr, W., Stephens, D.N., Schnieder, H., Seidelmann, D. and Schmiechen, R., Evaluation of the β-carboline ZK 93 426 as a benzodiazepine receptor antagonist, Psychopharmacology (Berlin), 83 (1984) 249-256.
23. [23] June, H.L., Lummis, G., Colker, R.E., Moore, T.O. and Lewis, M.J., RO15-4513 attenuates consumption of ethanol in deprived rats, Alcohol. Clin. Exp. Res., 15 (1991) 406-411.
24. [24] June, H.L., Colker, R.E., Domangue, K.R., Perry, L.E., Hicks, L.H., June, P.L. and Lewis, M.J., Ethanol self-administration in deprived rats: effects of RO15-4513 alone, and in combination with flumazenil (RO15-1788), Alcohol. Clin. Exp. Res., 15 (1992) 406-411.
25. [25] June, H.L., Greene, T.L., Murphy, J.M., Lumeng, L. and Li, T.-K., RO19-4603 selectively attenuates ethanol intake in the alcohol-preferring (P) rats. [abstract] Alcohol. Clin. Exp. Res., 17 (1993) 48.
26. [26] June, H.L., Hughes, R.W., Spurlock, H.L. and Lewis, M.J., Ethanol self-administration in freely feeding rats: effects of RO15-4513 alone, and in combination with flumazenil (RO15-1788), Psychopharmacology (Berlin), 115 (1994) 332-339.
27. [27] June, H.L., Murphy, J.M., Mellor-Burke, J.J., Lumeng, L. and Li, T.-K., RO19-4603 exerts prolonged and selective suppression of ethanol intake in the alcohol-preferring (P) rats, Psychopharmacology (Berlin), 115 (1994) 332-339.
28. [28] June, H.L., Duemler, S., Greene, T.L., Williams, J., Lin, M., Chen, S.H.A., Lewis, M.J. and Murphy, J.M., Effects of RO19-4603 on the maintenance of tolerance to a single dose of ethanol, J. Pharmacol. Exp. Ther., 247 (1995) 1105-1112.
29. [29] June, H.L., Murphy, J.M., Hewitt, R.L., Greene, T.L., Lin, M., Lumeng, L. and Li, T.-K., Benzodiazepine receptor ligands with different intrinsic efficacies alter ethanol intake in the alcohol-nonpreferring (NP) rats, Neuropsychopharmacology, 14 (1996) 55-66.
30. 3H]RO 15-4513 binding. In G. Biggio, A. Concas and E. Costa (Eds.), GABAergic Synaptic Transmission, Raven Press, New York, 1992, pp. 289-299.
31. [31] Li, T.-K., Crabb, D.W. and Lumeng, L., Molecular and genetic approaches to understanding alcohol-seeking behavior. In R.E. Meyer, G.F. Koob, M.J. Lewis and S.P. Paul, (Eds.), Neuropharmacology of Ethanol, Birhauser, Boston, 1991, pp. 107-124.
32. [32] Lister, R., Behavioral interactions between ethanol and imidazobenzodiazepines with high affinities for the benzodiazepine receptors, Life Sci., 42, (1988) 1385-1386.
33. [33] Lister, R.G., Greenbalt, D.J., Abernethy, D.R. and File, S.E., Pharmacokinetic studies on RO15-1788, a benzodiazepine receptor ligand in the brain of the rat, Brain Res., 290 (1984) 183-186.
34. [34] Lister, R.G. and Durcan, M.J., Antagonism of the intoxicating effects of ethanol by the potent benzodiazepine receptor ligand RO19-4603, Brain Res., 482 (1989) 141-144.
35. [35] Lister, R.G. and Nutt, D.J., Interactions of the imidazobenzodiazepine Ro15-4513 with chemical convulsants, Br. J. Pharmacol., 93 (1988) 210-214.
36. [36] Lumeng, L., Hawkins, T.D. and Li, T.-K., New strains of rats with alcohol preference and nonpreference. In R.G. Thurman, J.R. Williamson, H. Drott and B. Chance (Eds.), Alcohol and Aldehyde Metabolizing Systems, Academic Press, New York, 1977, pp. 537-544.
37. [37] Mandema, J.W., Kuck, M.T. and Danhoff, M., In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy, J. Pharmacol. Exp. Ther., 261 (1992) 56-61.
38. [38] Martin, J.R., Pieri, L., Bonnetti, E.P., Schaffner, R. and Burkard, W.P., RO16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor, Pharmacopsychiatry, 21 (1988) 360-363.
39. [39] McBride, W.J., Murphy, J.M., Lumeng, L. and Li, T.-K., Effects of RO15-4513, fluoxetine, desipramine on the intake of ethanol, water and food by the alcohol-preferring (p) and nonpreferring (np) lines of rats, Pharmacol. Biochem. Behav., 30 (1988) 1045-1050.
40. 3H] Ro15-4513 in rat brain, Eur. J. Pharmacol., 153 (1988) 141-145.
41. [41] Mhatre, M. and Ticku, M.K., Chronic ethanol treatment selectively increases the binding of inverse agonists for benzodiazepine binding sites in cultured spinal neurons, J. Pharmacol. Exp. Ther., 251 (1989) 164-168.
42. A receptor-gated chloride ion channel. In R.E. Meyers, G.F. Koob, M.J. Lewis and S.M. Paul (Eds.), Neuropharmacology of Ethanol, Birkhauser, Boston, 1991, pp. 49-76.
43. [43] Murphy, J.M., Gatto, G.J., Waller, M.B., McBride, W.J., Lumeng, L. and Li, T.-K., Effects of scheduled access on ethanol intake by the alcohol-preferring (P) line of rats, Alcohol, 3 (1986) 331-336.
44. [44] Olsen, R., Drug interactions at the GABA receptor-ionophore complex, Annu. Rev. Pharmacol. Toxicol., 22 (1982) 245-277.
45. [45] Penn, P.E., McBride, W.J., Lumeng, L., Gaff, T. and Li, T.-K., Neurochemical and behavioral studies of a strain of alcohol-preferring rats, Pharmacol. Biochem. Behav., 8 (1978) 475-481.
46. [46] Pieri, L., Ro 19-4603: A benzodiazepine receptor partial inverse agonist with prolonged proconvulsant action in rodents [abstract], Br. J. Pharmacol., 95 (1988) 477.
47. [47] Pieri, L., Biry, P. and Wdonwicki, G., A novel benzodiazepine receptor partial inverse agonist RO15-3505, Br. J. Pharmacol., 86 (1985) 592.
48. [48] Rassnick, S., D'Amico, E., Riley, E. and Koob, G.F., GABA antagonist and benzodiazepine partial inverse agonist reduces motivated responding for ethanol, Alcohol. Clin. Exp. Res., 17 (1993) 124-130.
49. [49] Reimann, I.W., Jedrychowski, M., Schulz, R., Antonin, K.-H., Roth, A. and Bieck, P.R., Pharmacokinetic and pharmacodynamic effects of the novel benzodiazepine antagonist 2-phenylpyrazolo(4,3-c)quinolin-one in humans, Arzheim-Forsch/Drug Res., 37 (1987) 1174-1178.
50. [50] Samson, H.H., Initiation of ethanol-maintained behavior: a comparison of animal models and their implication to human drinking. In T. Thompson, P. Dews and J. Barret (Eds.), Advances in Behavioral Pharmacology: Neurobehavioral Pharmacology, Vol. 6, Hillsdale Lawrence Erlbaum Associates, New Jersey, 1987, pp. 221-241.
51. [51] Samson, H.H., Haraguchi, M., Tolliver, G.A. and Sadeghi, K.G., Antagonism of ethanol-reinforced behavior by the benzodiazepine inverse agonists Ro15-4513 and FG 7142: relationship to sucrose reinforcement, Pharmacol. Biochem. Behav., 33 (1989) 601-608.
52. [52] Suzdak, P.D., Paul, S.M. and Crawley, J.N., Effects of Ro 15-4513 and other benzodiazepine receptor inverse agonists on alcohol-induced intoxication in the rat, J. Pharmacol. Exp. Ther., 245 (1988) 880-886.
53. [53] Ticku, M.K. and Kulkarni, L.K., Molecular interactions of ethanol with GABAergic system and potential of Ro15-4513 as an ethanol antagonist, Pharmacol. Biochem. Behav., 30 (1988) 501-510.
54. [54] Ticku, M.K., Mhatre, M. and Mehta, A.K., Modulation of GABAergic transmission by ethanol. In G. Biggio, A. Concas and E. Costa (Eds.), GABAergic Synaptic Transmission, Raven Press, New York, 1992, pp. 255-268.
55. [55] Waller, M.B., McBride, W.J., Gatto, G.J., Lumeng, L. and Li, T.-K., Intragastric self-infusion of ethanol by ethanol-preferring and nonpreferring lines of rats, Science, 225 (1984) 78-80.
56. [56] Wegelius, K., Honkanen, A. and Korpi, E.R., Benzodiazepine receptor ligands modulate ethanol drinking in alcohol-preferring rats, Eur. J. Pharmacol., 263 (1994) 141-147.
57. [57] Weiss, F. and Koob, G.F., Neuropharmacology of ethanol. In R.E. Meyers, G.F. Koob, M.J. Lewis and S.M. Paul (Eds.). Neuropharmacology of Ethanol, Birkhauser, Boston, 1991, pp. 49-76.
58. [58] Wong, G. and Skolnick, P., High affinity ligands for 'diazepam-insensitive' benzodiazepine receptors, Eur. J. Pharmacol., 225 (1992) 63-68.